What are the clinical features of motor neurone disease (amyotrophic lateral sclerosis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Features of Motor Neurone Disease (Amyotrophic Lateral Sclerosis)

Core Presentation

Motor neurone disease, particularly ALS, presents with a characteristic combination of upper motor neuron signs (hypertonicity, hyperreflexia, extensor plantar responses) and lower motor neuron signs (muscle fasciculations, weakness, atrophy, hyporeflexia) affecting bulbar, limb, and respiratory musculature in a progressive pattern. 1, 2

Upper Motor Neuron Features

  • Spasticity with increased muscle tone and velocity-dependent resistance to passive movement 2
  • Hyperreflexia manifesting as brisk or exaggerated deep tendon reflexes 3, 2
  • Extensor plantar response (Babinski sign) indicating corticospinal tract involvement 2
  • Clonus showing rhythmic muscle contractions in response to sudden, maintained stretch 2

Lower Motor Neuron Features

  • Fasciculations are the most characteristic sign of lower motor neuron damage, appearing as spontaneous visible muscle twitches that originate from the motor neuron or distally along the axon 2
  • Progressive muscle weakness and atrophy developing due to denervation 2, 4
  • Hypotonia resulting from interruption of normal neural input 2
  • Hyporeflexia or areflexia with diminished or absent deep tendon reflexes 2
  • Flaccid paralysis characterized by decreased muscle tone with weakness 2

Pattern of Disease Progression

  • Focal onset with weakness typically starting in the legs and progressing to the arms and cranial muscles, though onset can be asymmetrical or begin in different regions 1, 5
  • Relentless progression with spread within a region or to other regions over time 1
  • Patients typically reach maximum disability within 2 weeks of symptom onset; if progression occurs within 24 hours or after 4 weeks, alternative diagnoses should be considered 3

Bulbar Involvement

  • Dysarthria (speech difficulties) affecting approximately 80% of patients with bulbar-onset ALS 6
  • Dysphagia (swallowing difficulties) present in approximately 80% of bulbar-onset cases 6
  • Difficulties with functions controlled by lower cranial nerves including tongue weakness and impaired palatal movement 6
  • Emotional lability may occur with pseudobulbar palsy (upper motor neuron bulbar dysfunction) 1

Respiratory Manifestations

  • Progressive respiratory compromise due to respiratory muscle weakness 4, 7
  • Respiratory failure is the most common cause of death in ALS 6
  • Median survival of 3-4 years after symptom onset, though 5-10% of patients survive longer than 10 years 3, 6

Associated Features

  • Dysautonomia including blood pressure or heart rate instability, pupillary dysfunction, and bowel or bladder dysfunction 3
  • Pain is frequently reported and can be muscular, radicular, or neuropathic in character 3
  • Fatigue and sleep disorders are common complications 4
  • Extra-motor manifestations occur in up to 50% of cases, including behavioral changes, executive dysfunction, and language problems; 10-15% meet criteria for frontotemporal dementia 5

Clinical Variants

  • Pure motor variant with weakness without sensory signs 3, 1
  • Progressive bulbar palsy with primary involvement of bulbar muscles first 1
  • Progressive muscular atrophy involving only lower motor neurons without upper motor neuron signs 1
  • Primary lateral sclerosis with pure upper motor neuron involvement 8
  • Pharyngeal-cervical-brachial weakness limited to upper limbs 3
  • Paraparetic variant with weakness limited to lower limbs 3

Critical Diagnostic Pitfalls

  • Reflexes may be normal or even exaggerated in some patients with atypical ALS, particularly those with pure motor variant and AMAN subtype on electrophysiology 3
  • Sensory symptoms should prompt reconsideration of pure motor neuron disease, as sensory pathways are not typically involved 2
  • Young children (<6 years) can present atypically with poorly localized pain, refusal to bear weight, irritability, meningism, or unsteady gait rather than classic weakness 3

Epidemiology

  • ALS represents approximately 85% of all motor neuron disease cases 3, 1
  • 85-90% of cases are sporadic with no family history 3
  • Annual incidence of 1-2 per 100,000 population 3, 1
  • 10% have autosomal dominant inheritance pattern (familial ALS) 5

References

Guideline

Motor Neuron Disease Characteristics and Diagnostic Features

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Motor Neuron Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation and rehabilitation of patients with adult motor neuron disease.

Archives of physical medicine and rehabilitation, 1999

Research

Amyotrophic lateral sclerosis: a clinical review.

European journal of neurology, 2020

Guideline

Diagnostic and Treatment Approaches for Amyotrophic Lateral Sclerosis (ALS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.